James Lawless
Ceist:1268. Deputy James Lawless asked the Minister for Health if his attention has been drawn to the UK’s competition and markets authority decision to investigate the manufacturers of the medicine Remicade as a result of the latter’s alleged abuse of a dominant market position arising from its use of an anti-competitive discount scheme intended, it is alleged, to prevent the use of more affordable biosimilar medicines; if his attention has been further drawn to similar practices in the market in Ireland; his views on whether a similar investigation is required in Ireland; and if he will make a statement on the matter. [27675/17]
Amharc ar fhreagra